Paediatrics Publications

Document Type


Publication Date



British Journal of Pharmacology





First Page


Last Page


URL with Digital Object Identifier



BACKGROUND AND PURPOSE A common site for drug binding on voltage-gated ion channels is at the interior face of the channel pore. In this study, we tested the hypothesis that the extent of drug block of the human cardiac KCNA5 (K v1.5) channel underlying the atrial-specific, ultra-rapidly activating, delayed K + current (I Kur) is modulated by the drug uptake and efflux transporters encoded by organic cation transporter 1 (OCTN1) and multiple drug-resistant gene 1 (MDR1) and expressed in human heart. EXPERIMENTAL APPROACH Drug block of KCNA5 was assessed in Chinese hamster ovary cells transiently transfected with KCNA5 alone or in combination with the OCTN1 or MDR1 transporter construct, as well as in an MDR1 stably expressed cell line. KEY RESUTLS Co-expression of OCTN1 significantly facilitated block by quinidine (10-μM), verapamil (20-μM), propafenone (5-μM) and clofilium (30-μM). Further evidence of drug transport modulating drug block was the finding that with OCTN1, block developed faster and only partially washed-out, and that block potentiation was prevented by cimetidine, an inhibitor of OCTN1. MDR1 expression attenuated KCNA5 block by erythromycin (an MDR1 substrate). Block was restored by reversin-205 (10-μM, an MDR1 inhibitor). MDR1 did not affect KCNA5 inhibition by KN-93 (1-μM), a blocker acting on the outer mouth of the channel pore. CONCLUSIONS AND IMPLICATIONS The extent of drug block of KCNA5 can be modulated by drug uptake and efflux transporters. These data provide further support for the idea that modifying intracellular drug concentrations could modulate the effects of blocking ion channels in patients. © 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.